The most useful signal in this public health dataset is not the number of formal procurement notices. It is the mismatch between pressure and pipeline. Across 80 relevant insights from 24 councils, there are 34 pressure signals but only 12 opportunity signals and no listed procurement opportunities in the extracted pipeline. That does not mean the market is quiet. It means councils are under strain, reshaping services, extending incumbents, and preparing targeted recommissioning before opportunities become fully visible.
For suppliers, that is a market-stage clue. Public health teams are not talking about broad transformation for its own sake. They are talking about drug deaths, collapsing vaccination uptake, oral health outliers, illegal vape enforcement, sexual violence hotspots, clean air, and ageing populations. The commercial opportunity sits in the gap between those operational problems and the council machinery needed to respond: needs assessments, partnership design, pathway redesign, contract extensions, direct awards, data-led interventions, and specialist delivery capacity.
The market signal: pressure is high, but councils are not buying in a conventional way
The sector breakdown is blunt. Of the 80 public-health-related insights, 34 are pressure-led, 15 concern policy, 15 concern spending, 12 are opportunities, and only 4 are actions. In other words, councils are spending a lot of meeting time describing problems and resetting strategy, not launching lots of clean, open tenders.
That matters commercially because public health often moves through three stages before procurement appears:
- a pressure becomes undeniable in committee papers or board discussions;
- a needs assessment, strategy reset, or contract extension buys time;
- only then does formal commissioning emerge.
This pattern is visible throughout the data. One authority said, on drugs and alcohol, that "this year we're undertaking new needs assessment ... we have commissioned the Drug and Alcohol Partnership through Public Health and Commission of the Care Forum to work with the partnership ... hoping to come to kind of a final draft in August ... finalise recommendations in September". That is not yet a tender, but it is exactly the kind of pre-market motion suppliers should track.
Residents should read this another way. A lot of public health activity is happening before the public sees a contract award or a new service launch. The debate is already under way in scrutiny rooms and health boards, often in response to worsening outcomes.
Drugs and alcohol is the clearest live commissioning market
If there is one area where public health looks most commercially active, it is substance misuse. Councils and partnerships are discussing both immediate pressure and multi-year service structures.
One meeting recorded that "funding for Public Health Commission services for drugs and alcohol last year was just over £1.8 million ... last year we had just under £350,000 of grant funding". That points to an existing commissioning base of roughly £2.15 million when grant is included. Another authority went much further, approving a comprehensive recommissioning of community drug and alcohol services with a maximum annual value of "£5,265,903" and "an estimated total cost of just under £50 million over the 9-year period." That is one of the biggest explicit long-term public health contract signals in the dataset.
There is also evidence that some councils are prioritising continuity over competition. In one cabinet discussion, members approved a direct appointment of the incumbent provider, saying: "we're proposing a direct appointment of existing provider ... this is not an open procurement process ... we commission them for the next 5 years with an option to extend that by another two years." For challengers, that is a warning: some authorities facing clinical risk and operational fragility will choose provider stability over market testing.
But continuity does not mean the market is closed. It means suppliers need a different entry strategy. Councils are commissioning lived-experience engagement, pathway redesign, targeted harm reduction, and specialist support around core contracts. The meeting quote about final draft recommendations in August and September is a timing signal: engagement has to happen during strategy reset, not after procurement publication.
The underlying need is severe. Midlothian Council reported: "our figures in 2023 saw an increase to 20 drug deaths. It was four in 2022, however, just to stress that was an outlier in 2022". Edinburgh City Council heard even starker evidence: "In the last two years, 2022 and 2023, the cumulative Edinburgh city death toll is 224. Last year alone, 2023, 111". North Ayrshire had earlier described 38 drug deaths in one year, adding that "every one of them is a tragedy".
This is more than a social policy issue. It is a commissioning market around outreach, recovery support, inpatient detox pathways, peer support, psychosocial interventions, data analysis, and geographic targeting. When deaths are being mapped to hotspots in Leith, Gorgie and Wester Hailes, or when deprivation is said to make drug deaths 15 times more likely, place-based delivery becomes commercially relevant.
Targeted prevention is replacing broad-brush public health delivery
A second strong pattern is councils becoming much more selective about who gets prevention services and how. North Ayrshire Council provides a clear example from community safety, with a model that other public health services may follow. Officials said: "We've seen 631 home safety visits being conducted within the first 6 months of this year. We see 29% of those were high-risk visits and we will see that increase change as we move into a new process of home fire safety visits where we will only be doing higher risk visits".
That is a classic resource-constrained redesign: less universalism, more risk stratification, more reliance on referral pathways and partner intelligence. Suppliers offering triage tools, referral management, population risk analytics or targeted behaviour-change support should pay attention. Councils are not abandoning prevention; they are narrowing it.
The same logic appears in vaccination. Leicester City Council was unusually candid: "Uptake in schools remains pretty poor, 27% of school children currently having flu vaccination...the uptake in the city is pretty much half of what it is in the county for both of those. And there's...it's unacceptable." This is a service redesign signal. The problem is not lack of awareness of the issue; it is the failure of the current model to shift entrenched uptake.
For suppliers, that suggests demand for hyper-local engagement, school-based communications, community ambassador models, behavioural insight work, and delivery redesign that distinguishes primary from secondary settings. For residents, it means the gap is no longer abstract. A city is openly acknowledging that its children are being vaccinated at roughly half the rate of surrounding areas.
Oral health is moving from routine concern to reputational problem
Children’s oral health stands out because the data shows not just poor performance, but an extreme outlier. At a City of Wolverhampton Council meeting, members were told that Wolverhampton was "an outlier ... with the most for the highest prevalence of experience of decay out of all local authorities that contributed to the survey". The figure behind that is 43% of Year 6 children with decay experience, compared with 33% for the next highest authority.
A 10-point gap above every other participating authority is not business as usual. It creates pressure for visible intervention, especially where historical programmes have focused more heavily on younger children than older cohorts. This is where suppliers should expect demand for supervised brushing expansion, whole-school oral health models, secondary-school prevention, targeted community engagement, and better use of epidemiological data.
There is also a process clue here. Another board discussion noted that "we won't be able to retake the item number eight today, the oral health strategy for various reasons. so we deferred that probably to the next meeting." Deferral is easy to dismiss, but commercially it matters. If a strategy slips, commissioning and service redesign usually slip with it. Bid teams should monitor agendas, not just procurement portals.
Public health enforcement is becoming a more active sub-market
Some of the sharpest public health discussions in local government are no longer about lifestyle campaigns. They are about enforcement: vapes, alcohol licensing, illicit tobacco, and the health harms connected to the nighttime economy.
Birmingham City Council heard evidence that police had seized "over 400 illegal vapes" and referred to "two photographs of vapes with excess puff capacity of the legal limit". The legal basis was set out clearly: "The nicotine inhaling products age of sale and proxy purchasing regulations 2015 state that electronic cigarettes, e-cigs or vapes as we call them, that contain nicotine must not be sold or supplied to any person under the age of 18."
In Wolverhampton, a mini market was found in repeated breach, with officers reporting that "there was no incident book... all staff had not had training and refresher training every six months... all staff had not been trained in challenge 25". Harrow discussed restrictions on high-strength alcohol and miniature bottles. Sheffield used public health evidence in licensing, pointing to "43 sexual assaults and violence" and "60 cases of antisocial behaviour" within 200 metres of a premises over 12 months.
These are not fringe issues. They point to a growing market for regulatory support, evidence packs, retailer engagement, test purchasing operations, licensing analytics, place-based violence prevention, and training around compliance. They also show public health teams working more closely with trading standards, licensing and police. Suppliers that can bridge those functions will be more useful than those selling a stand-alone public health service.
For the public, this matters because licensing decisions are increasingly being argued through a health lens rather than just nuisance or crime. When Sheffield links alcohol availability to an area where intoxication is present in around half of sexual assaults, the council is signalling that public health evidence now has operational weight in local regulatory decisions.
Health inequalities are driving long-range strategy, but councils want measurable delivery
Wiltshire Council’s Joint Strategic Needs Assessment 2025 is one of the clearest examples of a council tying long-term demographics to present commissioning choices. Members were told: "by 2045 our population aged 65 years and over will have increased by 40%. Um this is equivalent to about 47 a half thousand people... people living in more deprived areas um have significantly shorter life expectancy".
This is familiar in one sense; every authority talks about ageing and deprivation. What is more useful here is the scale and the explicit connection to health inequality. It suggests demand for prevention that is geographically and demographically segmented, not county-wide in a generic sense.
Doncaster gives a similar strategic narrowing. Its revised health and wellbeing strategy to 2030 has "three areas of focus": "Clos[ing] the women's and child health Gap... improve the experience of aging... and then we want to create healthy places". That kind of prioritisation matters. It means councils are becoming more willing to deprioritise lower-status activity and concentrate spend and partnership effort on fewer themes.
Clean air is another example. Cabinet backed a 15-year strategy, stating that it asked members to "endorse and approve the clean air strategy 26 to 2040 and the mission statement and strategic actions it sets out." The commercially important point is not just the strategy horizon. It is that the strategy includes WHO-aligned targets, five-year staging posts and KPIs. Suppliers should assume that future work in air quality and healthy places will need stronger evidence, measurement and delivery reporting.
Staffing shortages are creating demand even where procurement is not visible
Some councils are being held back not only by money, but by lack of specialist capacity. Pembrokeshire County Council described a serious staffing problem in public protection, saying: "Food Safety and Standards, for example, we do have a current 44% shortfall in the team's full capacity, which is the equivalent of about six members of staff... we have tried to recruit on a number of of occasions but unfortunately we have failed to recruit into those replacement roles".
This is one of the most underappreciated commercial signals in the dataset. Where councils cannot recruit environmental health, trading standards, housing standards or communicable disease staff, they often resort to:
- interim professional cover;
- outsourced inspection or compliance support;
- specialist consultancy;
- shared service models;
- digital tools that reduce officer workload.
The public-health market is therefore not just about big programme contracts. It is also about capacity substitution. Suppliers that can provide credible, regulated, hard-to-recruit expertise may find easier entry than firms pitching broad transformation language.
Capital and adjacent spend: not all public health opportunity sits inside the public health budget line
The absence of listed procurement opportunities in the structured pipeline should not fool anyone into thinking there is no money moving. Several adjacent or blended investments matter.
North Lanarkshire Council reported: "We spent £325,000 last year in terms of purchasing those hybrid alarms, and we've still got about £1.275 million of capital funding remaining in the budget to support this process". That is not a classic public health contract, but it sits squarely in prevention, community safety and independent living.
Sheffield approved "£7.28 million for the period of September this year to March 2030" for Connect to Work, including "commissioning of community-based delivery providers". Again, not pure public health, but deeply relevant to wider determinants of health and employability support.
And where sexual and reproductive health is concerned, the extension with Lewisham and Greenwich NHS Trust shows another route councils are taking: keep services within established NHS partnerships rather than reprocure into the open market. Members said the extension would "ensure continuity of a high-performing, open access service" that meets statutory duties. For suppliers, that means some opportunities will come through NHS partnership chains, subcontracting, digital enablement or service improvement support rather than direct council contract awards.
What this sector is really saying
The public health market in local government is not signalling a flood of easy, open competitions. It is signalling something more demanding and, for informed suppliers, more useful.
Councils are saying five things very clearly.
First, they will spend where harm is acute and measurable: drug deaths, vaccine failure, oral health outliers, illegal vape sales, unsafe premises, poor air quality.
Second, they increasingly want targeted interventions, not universal programmes with weak evidence.
Third, many will protect incumbent clinical or treatment pathways if the risk of disruption is too high.
Fourth, strategy and needs assessment work is often the real pre-procurement stage.
Fifth, shortages in specialist staff are themselves a market driver.
For residents and local journalists, this means public health is becoming more visible in licensing, enforcement, place management and environmental decisions, not just in NHS-facing services. For suppliers, it means the best opportunities are often identifiable months before a tender appears.
Actionable takeaways
For suppliers and bid teams
- Track drugs and alcohol commissioning first. The clearest budgeted market signals are here, from the £1.8 million-plus commission base and grant-backed add-ons to the £5.265 million annual recommissioning model and nearly £50 million nine-year pipeline discussed in cabinet.
- Engage during needs assessment windows, not after. The partnership expecting a draft in August and recommendations in September is exactly the stage when service models can still be influenced.
- Build offers around targeted prevention. Leicester’s 27% school flu uptake and North Ayrshire’s shift to high-risk-only visits show councils want segmented delivery, referral intelligence and measurable impact.
- Treat public protection and enforcement as part of the public health market. Birmingham, Wolverhampton, Harrow and Sheffield all show opportunities around compliance, retailer training, evidence support and licensing analytics.
- Watch delayed strategy items. Oral health deferrals can shift commissioning dates, but they do not remove need. Wolverhampton’s 43% decay rate makes future intervention hard to avoid.
For residents and civic observers
- Pay attention to licensing and regulatory committees as well as health boards. Some of the clearest public health decisions are being made there.
- Ask whether targeted approaches are excluding lower-risk groups who still need support. Councils are narrowing provision under pressure.
- Watch whether poor outcomes turn into funded action. Leicester’s vaccination gap and Wolverhampton’s oral health outlier are now well documented in public.
For NHS and delivery partners
- Expect councils to favour stable partnerships where statutory risk is high, as seen in sexual and reproductive health extensions and direct awards in drug and alcohol treatment.
- Come to councils with data, not just service descriptions. WHO-aligned clean air KPIs, hotspot mapping and deprivation analysis are shaping decisions.
- Be ready for integrated solutions. The strongest signals cut across public health, social care, licensing, trading standards, environmental health and community safety.